Dergiler / Joint diseases and related surgery / 2021 / Cilt: 32 - Sayı: 3

The relationship of systemic inflammatory biomarkers andcardiac parameters with malignancy in patients withsoft tissue tumors located in the extremity

Sayfa
698–704
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There was no significant difference betweenthe control and benign groups (p=0.198 and p=0.553, respectively),while the NLR and PLR of the malignant group were higher than boththe control and benign groups, indicating a statistical significance(p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In this study, we aimed to investigate the contribution ofsystemic inflammatory biomarkers to the diagnosis and to examinethe relationship between cardiac parameters and malignancy inpatients with extremity soft tissue sarcomas (STSs).
📊
Temel Bulgular & Veri:Patients and methods: Between January 2011 and December 2020,a total of 256 patients (155 males, 101 females; median age: 50 years;range, 18 to 87 years) who were diagnosed with benign and malignantsoft tissue tumors were retrospectively analyzed.
💡
Sonuç & Katkı:There was no significant difference betweenthe control and benign groups (p=0.198 and p=0.553, respectively),while the NLR and PLR of the malignant group were higher than boththe control and benign groups, indicating a statistical significance(p
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: In this study, we aimed to investigate the contribution ofsystemic inflammatory biomarkers to the diagnosis and to examinethe relationship between cardiac parameters and malignancy inpatients with extremity soft tissue sarcomas (STSs). Patients and methods: Between January 2011 and December 2020,a total of 256 patients (155 males, 101 females; median age: 50 years;range, 18 to 87 years) who were diagnosed with benign and malignantsoft tissue tumors were retrospectively analyzed. The control groupconsisted of a total of 150 age- and sex-matched healthy individuals(83 males, 67 females; median age: 52 years; range 19 to 76 years)with complete blood count analysis and having no STS. Demographiccharacteristics, laboratory parameters, and echocardiographic dataof the patients were obtained from the hospital database. Theneutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyteratio (PLR) were calculated. Results: Of a total of 256 patients included, 99 were diagnosed withbenign tumors and 157 with malignant tumors. Lipoma was observedwith the highest frequency of 40.4% among benign tumors, whilemalignant mesenchymal tumor (35.0%) was the most common tumorin the malignant group. There was no significant difference betweenthe control and benign groups (p=0.198 and p=0.553, respectively),while the NLR and PLR of the malignant group were higher than boththe control and benign groups, indicating a statistical significance(p

🔖

Bu Makaleye Atıf Yap

ÖZTÜRK, R., TOLUNAY, H., ARIKAN, Ş. M., TOLUNAY, T. (2022). The relationship of systemic inflammatory biomarkers andcardiac parameters with malignancy in patients withsoft tissue tumors located in the extremity. Joint diseases and related surgery, Cilt: 32 - Sayı: 3, 698–704. https://ajindex.com/articles/652229

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Öztürk R, Arıkan ŞM, Bulut EK, Kekeç AF, Çelebi F, Güngör BŞ. Distribution and evaluation of bone and soft tissue tumors operated in a tertiary care center. Acta Orthop Traumatol Turc 2019;53:189-94
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30
  3. Morii T, Kishino T, Shimamori N, Motohashi M, Ohnishi H, Honya K, et al. Differential diagnosis between benign and malignant soft tissue tumors utilizing ultrasound parameters. J Med Ultrason (2001) 2018;45:113-9
  4. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma 2010;2010:506182
  5. Zhang Y, Yue B, Zhao X, Chen H, Sun L, Zhang X, et al. Benign or malignant characterization of soft-tissue tumors by using semiquantitative and quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging. Can Assoc Radiol J 2020;71:92-9
  6. Liang Y, Wang W, Li J, Guan Y, Que Y, Xiao W, et al. Combined use of the neutrophil-lymphocyte and plateletlymphocyte ratios as a prognostic predictor in patients with operable soft tissue sarcoma. J Cancer 2018;9:2132-9
  7. Liu G, Ke LC, Sun SR. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysis. Medicine (Baltimore) 2018;97:e12176
  8. Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H, et al. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013;108:1677-83
  9. Atik OŞ. Is there something new and interesting in my article? Eklem Hastalik Cerrahisi 2019;30:69
  10. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98
  11. Böhning D, Holling H, Patilea V. A limitation of the diagnostic-odds ratio in determining an optimal cut-off value for a continuous diagnostic test. Stat Methods Med Res 2011;20:541-50
  12. Zogheib E, Cosse C, Sabbagh C, Marx S, Caus T, Henry M, et al. Biological scoring system for early prediction of acute bowel ischemia after cardiac surgery: The PALM score. Ann Intensive Care 2018;8:46
  13. Arıkan ŞM, Yapar A, Atalay İB, Toğral G, Pervane A, Güngör BŞ. Diagnostic and prognostic role of mean platelet volume and mean platelet volume/platelet ratio in the most common soft tissue sarcomas. Jt Dis Relat Surg 2021;32:204-9
  14. Idowu OK, Ding Q, Taktak AF, Chandrasekar CR, Yin Q. Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. Biom